Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - June 2013

Point of Care Systems for Biosurveillance

17 Jun 2013 - 17 Jun 2013 - Alexandria, VA, USA

Bookmark and Share

The National Strategy for Biosurveillance, 2013, is formulated around four core functions: 1) Scan and discern the environment; 2) Identify and integrate essential information; 3) Alert and inform decision makers; and 4) Forecast and advise Impacts.  This workshop will focus on the second core function – Identify and Integrate Essential Information.  This function is focused to expedite incident detection and assessment.  “Although all incidents have unique aspects, there are common elements of any national public health emergency.  As with a health care provider and a new patient, there are certain key questions asked to identify symptoms and narrow probable causes to assist with patient treatment.”  In order to fulfill this requirement the community must improve diagnostic capability, especially at point-of-care to enable accurate and timely collection of information for early detection and throughout an incident or outbreak.

A point-of-care (POC) system is a hospital or outpatient information system that includes bedside terminals, instrumentation, sensors, or other devices for capturing and entering data at the location where the patients receive their care.  Doctors and clinicians use POC systems to record directly the details of patient encounters, to review medical information, and to order tests, referrals, prescriptions, and other services related to the patient’s ailments.  Modern POC systems are being designed to replace many of the functions previously associated with paper documents.

POC systems are part of the future of biosurveillance.  A POC system facilitates the electronic capture of key diagnostic data that is directly or readily translated to computer-interpretable form.  POC systems typically include decision support tools like drug interactions and to even suggest diagnoses.  Ideally doctors and clinicians will have sensors that use naturally bodily fluids for initial diagnosis and then the information is transmitted directly into the POC system where further analysis is conducted and feedback provided to doctor or clinician in real time.  
Topics to be addressed will include:

·         Improve point of care (POC) diagnostics capabilities

·         Accurate and real time collection for physicians and clinicians

·         POC decision support capabilities – i.e. diagnoses and drug interactions

·         POC DNA sequencing

·         Link POC results to public health databases and near real time feedback mechanisms

·         Data standards for interoperability of POC system, the electronic health record, and biosurveillance-related databases

·         Data analysis and modeling supporting POC-generated data – i.e. determining relationship between the completeness of sampling of a population and the size of outbreaks of diseases that can be detected

Further information
Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos